Provided is a fat or oil having a high diacylglycerol content and rich in -linolenic acid, in which crystallization at low temperature is suppressed, and which hardly causes white turbidity or deposition. Specifically, provided is a fat or oil composition, which satisfies the following (1) to (4): (1) a content of -linolenic acid in constituent fatty acids of a fat or oil is 40 mass % or more; (2) a total content of a saturated fatty acid having 16 carbon atoms and a saturated fatty acid having 18 carbon atoms in the constituent fatty acids of the fat or oil is 6 mass % or less, and a content of the saturated fatty acid having 18 carbon atoms in the constituent fatty acids of the fat or oil is less than 3 mass %; (3) a content mass ratio of the saturated fatty acid having 16 carbon atoms (P) to the saturated fatty acid having 18 carbon atoms (S) , [(P)/(S)], in the constituent fatty acids of the fat or oil is 0.1 or more and less than 3.5; and (4) a content of diacylglycerols is 25 mass % or more.

Provided is a fat or oil having a high diacylglycerol content and rich in -linolenic acid, in which crystallization at low temperature is suppressed, and which hardly causes white turbidity or deposition. Specifically, provided is a fat or oil composition, which satisfies the following (1) to (4): (1) a content of -linolenic acid in constituent fatty acids of a fat or oil is 40 mass % or more; (2) a total content of a saturated fatty acid having 16 carbon atoms and a saturated fatty acid having 18 carbon atoms in the constituent fatty acids of the fat or oil is 6 mass % or less, and a content of the saturated fatty acid having 18 carbon atoms in the constituent fatty acids of the fat or oil is less than 3 mass %; (3) a content mass ratio of the saturated fatty acid having 16 carbon atoms (P) to the saturated fatty acid having 18 carbon atoms (S) , [(P)/(S)], in the constituent fatty acids of the fat or oil is 0.1 or more and less than 3.5; and (4) a content of diacylglycerols is 25 mass % or more.

The present invention relates to compositions comprising DHA, EPA, LA and GLA. The compositions may further comprise other omega-3 PUFAs, MUFAs, SFAs, gamma tocopherol, Vitamin A and Vitamin E. The compositions are useful for treating neurologic disorders. The compositions are administered chronically for the prevention and/or treatment of multiple sclerosis (MS) and other degenerative diseases.

The present invention relates to compositions comprising DHA, EPA, LA and GLA. The compositions may further comprise other omega-3 PUFAs, MUFAs, SFAs, gamma tocopherol, Vitamin A and Vitamin E. The compositions are useful for treating neurologic disorders. The compositions are administered chronically for the prevention and/or treatment of multiple sclerosis (MS) and other degenerative diseases.

Synthetic nutritional compositions for infants and young children up to the age of thirty-six months, particularly infant formulae and growing-up milks, vary according to gender and the age of the infant or young child. The compositions have been designed to ensure balanced growth and to prevent obesity in in-fancy and later in life.

Synthetic nutritional compositions for infants and young children up to the age of thirty-six months, particularly infant formulae and growing-up milks, vary according to gender and the age of the infant or young child. The compositions have been designed to ensure balanced growth and to prevent obesity in in-fancy and later in life.

Liquid food product suitable to manage the ketogenic diet, which comprises at least lipids, carbohydrates, fibers, proteins and water.

Liquid food product suitable to manage the ketogenic diet, which comprises at least lipids, carbohydrates, fibers, proteins and water.

An early in life nutritional intervention with a lipid component having both large lipid globules with phospholipids and an increased amount of palmitic acid in the sn-2 position in triglycerides were found to improve the fatty acid composition of cell membranes, in particular brain membranes.

The disclosure is in part directed to shelf-stable, emulsion-forming liquid compositions, liquid beverage compositions, and fatty acid vesicle-forming liquid compositions for increased neurosystem uptake of amino acids present in the compositions when consumed by a subject.